← Evidence map

TrialLeukemia2005

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia.

T S Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this paperpooled ittrialcites it

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia. | OpenQuestion